Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +55.02%
#2 Pons Pons +46.41%
#3 TENDIES TENDIES +40.12%
#4 PondCoin PondCoin +34.70%
#5 Magma Finance Magma Finance +33.49%
#6 Purr Purr +30.11%
#7 The Bitcoin Bull The Bitcoin Bull +28.85%
#8 StonkBroker StonkBroker +28.68%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +27.14%
#10 SkyAI SkyAI +26.65%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Settings
Language
ENGLISH
Currency
USD
Theme
NatureWise Biotech & Medicals Corporation NatureWise Biotech & Medicals Corporation

NatureWise Biotech & Medicals Corporation

4732
Rank in Stocks #28603
NatureWise Biotech & Medicals Corporation is a Taiwanese entity primarily... NatureWise Biotech & Medicals Corporation is a Taiwanese entity primarily engaged in the creation of pharmaceutical solutions. Its product lineup features LipoCol Forte, a capsule designed to address elevated cholesterol and triglyceride levels; PPL Taiwan green propolis; and NBM-BMX, an oral softgel formulation specifically developed for oncology treatment. The company was established in 2000 and maintains its headquarters in Taipei, Taiwan.
Share Price
$0.52945382
Market Cap
$25.57M
Change (1 day)
0.30%
Change (1 year)
-27.50%
Country
TW
Trade NatureWise Biotech & Medicals Corporation (4732)

Category

Healthcare
Revenue for NatureWise Biotech & Medicals Corporation (4732)
Revenue in Aug 2026 TTM: 0
According to NatureWise Biotech & Medicals Corporation latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for NatureWise Biotech & Medicals Corporation from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH